Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)

Yu Tang Chin, Zong Rong He, Chi Long Chen, Hsiao Ching Chu, Yih Ho, Po Yu Su, Yu Chen S.H. Yang, Kuan Wang, Ya Jung Shih, Yi Ru Chen, Jens Z. Pedersen, Sandra Incerpi, André Wendindondé Nana, Heng Yuan Tang, Hung Yun Lin, Shaker A. Mousa, Paul J. Davis, Jacqueline Whang-Peng

研究成果: 雜誌貢獻文章同行評審

2 引文 斯高帕斯(Scopus)

摘要

In the original article, we neglected to include the funder “E-Da Hospital, EDAHP107018” to Z-RH. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

原文英語
文章編號241
頁(從 - 到)241
期刊Frontiers in Endocrinology
10
發行號APR
DOIs
出版狀態已發佈 - 2019

ASJC Scopus subject areas

  • 內分泌學、糖尿病和代謝

指紋

深入研究「Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different K-RAS Status. Tetrac and NDAT induce anti-proliferation via integrin αvβ3 in colorectal cancers with different K-RAS status (Frontiers in Endocrinology (2019) 10:130 DOI:10.3389/fendo.2019.00130)」主題。共同形成了獨特的指紋。

引用此